Phase 2 construction for CNYBAC to make way for Upstate MIND, and genetic sequencing lab
Construction on Phase 2 of the Central New York Biotech Accelerator (CNYBAC) is under way and will include a build out of third floor to accommodate the Upstate MIND—the Medical Innovation and Novel Discovery Center that will feature a 70-seat capacity Theater-in-the MIND, high-tech collaborative infrastructure and open “collision” areas for innovators and entrepreneurs in the fields of science, medicine, engineering, business and product development.
Currently the CNYBAC houses wet-and-dry lab space, shared equipment and public conference space available for licensing to biomed and biotech entrepreneurial endeavors ready to incubate and/or accelerate commercialization of their innovation.
Upstate MIND will incorporate technology, transformative meeting and concept development space for business and scientific consults and mentors with Upstate experts and area industry leaders. The Theater-in-the-MIND will host TED talks, popular mini presentations on variety of issues and will also house the CNYBAC ‘Cultivate’ Education Series, a collection of presentations aimed at sharing biotech/biomed-related experiences and knowledge.
Phase 2 will also include the development of a Molecular Pathology Next Generation Sequencing Lab that will be used for genetic testing aimed an enhancing clinical effectiveness in a movement toward what is called precision medicine. An initiative of the National Institutes of Health, precision medicine is an approach to disease treatment and prevention that takes in account individual variability in genes, environment and lifestyle for each person.
“The establishment of the Upstate MIND and new Molecular Pathology Next Generation Sequencing Lab brings to our community a concept that makes Central New York relevant in the emerging area of precision medicine,” said Upstate Medical University’s Vice President for Innovation and Business Development Robert Corona, DO, MBA, who will lead the Upstate MIND initiative.
“The future of medicine is likely going to be driven by the analysis of genetic blueprints of disease, their protein products and personalizing therapies as a result of the analysis, which we will begin to do in this dedicated space,” said Corona, who also serves as chair of Upstate’s pathology department.
Construction on the Upstate MIND space is expected to be completed in December with an opening anticipated for Spring 2016.
Architect for the Phase 2 is The S/L/A/M Collaborative (SLAM), a national multi-disciplinary architecture firm offering architecture, planning, interior design, landscape and site planning, structural engineering and construction services that focuses on higher education, K-12 public/private education, healthcare and corporate market sectors. SLAM has offices in Syracuse, Boston, Glastonberry, Conn., and Atlanta.
SLAM’s area project portfolio includes SUNY Buffalo State Technology Building and SUNY Buffalo Kapoor Hall School of Pharmacy. It has also completed similar facilities for Western Michigan University, Duke and Emory universities, to name a few.
General contractor is Murnane Building Contractors Inc., with offices in Syracuse, Plattsburgh and Utica.
The CNY Biotech Accelerator, located at 841 E. Fayette St., in Syracuse, is aimed at helping biotech and biomedical for-profit companies become successful and commercialize their products. Potential entrepreneurial clients seeking licensed space within the CNYBAC may contact staff at 315-464-9288 to schedule a meeting and tour. The CNYBAC application is available online.
Kathi Durdon, MA, CCRP, serves as director of operations for CNYBAC; Kathleen Pazaras is the building manager.
Caption: Architects rendering of the Theater in the Mind build out for the CNY Biotechnology Accelerator